Author:
Morimoto Kenta,Juma Kevin Maafu,Yamagata Masaya,Takita Teisuke,Kojima Kenji,Suzuki Koichiro,Yanagihara Itaru,Fujiwara Shinsuke,Yasukawa Kiyoshi
Abstract
Abstract
Background
Recombinase uvsY from bacteriophage T4, along with uvsX, is a key enzyme for recombinase polymerase amplification (RPA), which is used to amplify a target DNA sequence at a constant temperature. uvsY, though essential, poses solubility challenges, complicating the lyophilization of RPA reagents. This study aimed to enhance uvsY solubility.
Methods
Our hypothesis centered on the C-terminal region of uvsY influencing solubility. To test this, we generated a site-saturation mutagenesis library for amino acid residues Lys91–Glu134 of the N-terminal (His)6-tagged uvsY.
Results
Screening 480 clones identified A116H as the variant with superior solubility. Lyophilized RPA reagents featuring the uvsY variant A116H demonstrated enhanced performance compared to those with wild-type uvsY.
Conclusions
The uvsY variant A116H emerges as an appealing choice for RPA applications, offering improved solubility and heightened lyophilization feasibility.
Funder
Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Japan Science and Technology Agency
Publisher
Springer Science and Business Media LLC